Literature DB >> 29511042

Chronic disease as risk multiplier for disadvantage.

Francisca Stutzin Donoso1.   

Abstract

This paper starts by establishing a prima facie case that disadvantaged groups or individuals are more likely to get a chronic disease and are in a disadvantaged position to adhere to chronic treatment despite access through Universal Health Coverage. However, the main aim of this paper is to explore the normative implications of this claim by examining two different but intertwined argumentative lines that might contribute to a better understanding of the ethical challenges faced by chronic disease health policy. The paper develops the argument that certain disadvantages which may predispose to illness might overlap with disadvantages that may hinder self-management, potentially becoming disadvantageous in handling chronic disease. If so, chronic diseases may be seen as disadvantages in themselves, describing a reproduction of disadvantage among the chronically ill and a vicious circle of disadvantage that could both predict and shed light on the catastrophic health outcomes among disadvantaged groups-or individuals-dealing with chronic disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  distributive justice; ethics; health care for specific diseases/groups; right to healthcare; social aspects

Mesh:

Year:  2018        PMID: 29511042     DOI: 10.1136/medethics-2017-104321

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Why have Non-communicable Diseases been Left Behind?

Authors:  Florencia Luna; Valerie A Luyckx
Journal:  Asian Bioeth Rev       Date:  2020-03-20

2.  Equity Is Key to Build Back Better after COVID-19: Prioritize Noncommunicable Diseases and Kidney Health.

Authors:  Valerie Ann Luyckx
Journal:  Kidney360       Date:  2021-02-01

Review 3.  Sustainable Development Goals relevant to kidney health: an update on progress.

Authors:  Valerie A Luyckx; Ziyad Al-Aly; Aminu K Bello; Ezequiel Bellorin-Font; Raul G Carlini; June Fabian; Guillermo Garcia-Garcia; Arpana Iyengar; Mohammed Sekkarie; Wim van Biesen; Ifeoma Ulasi; Karen Yeates; John Stanifer
Journal:  Nat Rev Nephrol       Date:  2020-11-13       Impact factor: 28.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.